NCT06837376 Effects of Metabolic Testing Data and Education on Attitudes and Beliefs Related to Carbohydrate Intake in Adolescent Female Athletes
| NCT ID | NCT06837376 |
| Status | Recruiting |
| Phase | — |
| Sponsor | PepsiCo Global R&D |
| Condition | Nutritional Deficiency |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-02-05 |
| Primary Completion | 2025-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-02-05 with a primary completion date of 2025-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Many studies have consistently shown that females across sports under consume carbohydrate. Registered dietitians working with athletes have also reported female athletes chronically under consume carbohydrate. The primary objective of this study is to compare the effectiveness of education versus education plus interpreted individual metabolic (exercise) testing results to change attitudes and beliefs of female athletes regarding carbohydrate intake. The secondary objective is to assess the effectiveness of the education alone on attitudes and beliefs towards consuming carbohydrate in female athletes. The study hypothesis is that education alone will not significantly impact attitudes and beliefs, and that metabolic testing and the interpretation of the individual results will alter attitudes and beliefs toward carbohydrate intake.
Eligibility Criteria
Inclusion Criteria: 1. Females aged between the ages of 13-19 years old 2. Non-smoker 3. Currently enrolled in an IMG Academy sport 4. Willing to fast overnight (10 hours) prior to testing (for metabolic testing group). 5. Understand the protocol and be able to give verbal and written informed consent for participation as well as obtain parental consent if \<18 years of age. 6. Must be fluent in English reading, writing, and speaking. 7. You are not employed by, or have a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If you are unsure if a company would be considered a competitor to Gatorade, let the study investigator know the name of the other company and the nature of your relationship to that company before you sign the informed consent 8. If subject has asthma, they may still participate in but will be required to bring their prescribed inhaler if placed in the metabolic testing group Exclusion Criteria: 1. Expulsion from school for any reason 2. Leaving the IMG sports team 3. Pregnant or planning to become pregnant 4. Participated in any other clinical trial in the past 30 day 5. Participated in any PepsiCo trial in the past 6 months 6. Physical injury that would prevent participation in exercise group
Contact & Investigator
Kris Osterberg, PhD, RD
PRINCIPAL INVESTIGATOR
PepsiCo R&D Life Sciences, Sports Science
Frequently Asked Questions
Who can join the NCT06837376 clinical trial?
This trial is open to female participants only, aged 13 Years or older, up to 19 Years, studying Nutritional Deficiency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06837376 currently recruiting?
Yes, NCT06837376 is actively recruiting participants. Contact the research team at kris.osterberg@pepsico.com for enrollment information.
Where is the NCT06837376 trial being conducted?
This trial is being conducted at Bradenton, United States.
Who is sponsoring the NCT06837376 clinical trial?
NCT06837376 is sponsored by PepsiCo Global R&D. The principal investigator is Kris Osterberg, PhD, RD at PepsiCo R&D Life Sciences, Sports Science. The trial plans to enroll 60 participants.